H.R. 3 Placed On Senate Calendar, But It’s Likely A Spending-Bill Shell

By Ariel Cohen / September 11, 2020 at 7:31 PM
House Democrats’ Medicare drug price negotiation bill, H.R. 3, was placed on the Senate calendar Friday afternoon (Sept. 11), but that doesn’t mean the Senate majority leader plans to take up drug pricing. H.R. 3 now could be called up by unanimous consent for debate on the Senate floor, but sources say it’s merely being used as a shell bill for Senate spending legislation. Senate Majority Leader Mitch McConnell (R-KY) opposes H.R. 3, and he has shown no interest in...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.